Guendalina Zuccari

55PUBLICATIONS
38CO-AUTHORS
Molecular targetsMedical bacteriologyCancer therapy (excl. chemotherapy and radiation therapy)NanomaterialsFree radical chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Aug 13, 2026
Amphiphilic Semisynthetic Triterpenoids Impair Survival Pathways and Suppress Clonogenic Growth in Multidrug-Resistant High-Risk Neuroblastoma.

|Jun 26, 2026
Non-Cytotoxic Benzyl Triphenyl Phosphonium Bromide Is Bactericidal on MRSA and Fully Inhibits Biofilm Formation by MRSA and MRSE.

|Sep 27, 2025
From Early Diagnoses to New Treatments for Liver, Pancreatic, Gastric, and Colorectal Cancers Using Carbon Nanotubes: New Chances Still Underexplored.

Silvana Alfei, Caterina Reggio, Guendalina Zuccari

|Jul 25, 2025
Carbon Nanotubes as Excellent Adjuvants for Anticancer Therapeutics and Cancer Diagnosis: A Plethora of Laboratory Studies Versus Few Clinical Trials.

Silvana Alfei, Caterina Reggio, Guendalina Zuccari

|Feb 25, 2025
Last Fifteen Years of Nanotechnology Application with Our Contribute.

Silvana Alfei, Guendalina Zuccari

|Jan 25, 2025
Ellagic Acid: A Green Multi-Target Weapon That Reduces Oxidative Stress and Inflammation to Prevent and Improve the Condition of Alzheimer's Disease.

Silvana Alfei, Guendalina Zuccari

Pageof 10

Frequent Collaborators

46 joint publications

Silvana Alfei

12 joint publications

Danilo Marimpietri

10 joint publications

Alessia Zorzoli

6 joint publications

Barbara Marengo